Aside from its HDAC11 inhibitory activity, this study aims to investigate the impact of FT895 treatment on MPNST cells, particularly focusing on mitochondrial dysfunction since TAZ is involved in the synthesis of phospholipid cardiolipin, a key component of the inner mitochondrial membrane. Here, HDAC11 is linked to malignant peripheral nerve sheath tumor.